The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The United States transfection technologies market is expected to exhibit moderate growth during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Transfection technology is the process of artificially introducing nucleic acids like Ribonucleic Acid (RNA), Deoxyribonucleic Acid (DNA) and oligonucleotides into the eukaryotic cells. It can be introduced using physical, biological and chemical methods, which help in modifying certain properties of the cell. It includes cationic lipid transfection, electroporation, transfection and in-vivo transfection. At present, it is widely utilized for genomic studies that include screening, gene expression, Vivo research and RNA interference in the United States.
The transfection technologies market in the US is mainly driven by the rising cases of infectious diseases that require antibiotics. Additionally, the growing utilization of cell-based products is catalyzing the demand for transfection methods to treat chronic diseases, such as tuberculosis, cancer, and cardiovascular diseases in the US. Apart from this, reagent-based transfection technology is significantly expanding due to its cost-effectiveness and accuracy. It includes biolistic technology, laserfection and microinjection, which is impelling the growth of the market in the country. Besides this, the leading manufacturers are focusing on investing in the research and development (R&D) of cancer therapeutics, advanced cytological studies and precision medicine, which is creating a positive outlook for the market growth. Furthermore, growing investments by both governing and private organizations to develop large-scale transfection facilities and extensive research and development (R&D) activities in the field of protein therapeutics are driving the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the United States transfection technologies market report, along with forecasts for growth at the country and regional level from 2021-2026. Our report has categorized the market based on product type, application, transfection method, technology and end user.
Breakup by Product Type:
Breakup by Application:
Breakup by Transfection Method:
Breakup by Technology:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
|Base Year of the Analysis||2020|
|Segment Coverage||Product Type, Application, Transfection Method, Technology, End User, Region|
|Region Covered||Northeast, Midwest, South, West|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at